Gelteq Ltd

Listed Company
GELSCIK 0001920092NasdaqNon-AcceleratedEmerging GrowthPharmaceutical PreparationsC3AUFY ends Jun 30
Period
FY 2025
Revenue
Net Income
$-6.65M
Total Assets
$21.48M
Equity
Shares Out
9.44M
Op. Cash Flow

Business

Gelteq Ltd develops and commercializes white label gel-based delivery solutions that transform pharmaceuticals, nutraceuticals and other consumables into edible gel dosage forms. Its main products and services are patent-pending multiple-ingredient edible gels, gelification processes, taste-masking and texture customization, plus manufacturing and licensing of white-label gel products. The company organizes offerings across five core verticals—pets, sports, pharmaceutical, over-the-counter (OTC) and nutraceuticals—leveraging R&D and patent families. Gelteq distributes through licensing and white-label manufacturing partners and sells via partners and online channels across Australia, the U.S., China and the Asia‑Pacific region.

Summary from filing dated 2025-11-17

Financials

Latest annual snapshot (FY2025, period end 2025-06-30). Full statement history unavailable for this entity.

Revenue
Net income$-6.65M
Total assets$21.48M
Total liabilities$5.67M
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro